- Home
- HKD vs OPT Comparison
HKD vs OPT Comparison
Compare HKD & OPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKD
- OPT
- Stock Information
- Founded
- HKD 2003
- OPT 1984
- Country
- HKD France
- OPT Australia
- Employees
- HKD N/A
- OPT N/A
- Industry
- HKD Finance: Consumer Services
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HKD Finance
- OPT Health Care
- Exchange
- HKD Nasdaq
- OPT Nasdaq
- Market Cap
- HKD 689.8M
- OPT 767.9M
- IPO Year
- HKD 2022
- OPT 2020
- Fundamental
- Price
- HKD $2.73
- OPT $3.24
- Analyst Decision
- HKD
- OPT Strong Buy
- Analyst Count
- HKD 0
- OPT 1
- Target Price
- HKD N/A
- OPT $12.00
- AVG Volume (30 Days)
- HKD 309.2K
- OPT 39.0K
- Earning Date
- HKD 01-01-0001
- OPT 08-30-2024
- Dividend Yield
- HKD N/A
- OPT N/A
- EPS Growth
- HKD N/A
- OPT N/A
- EPS
- HKD 0.33
- OPT N/A
- Revenue
- HKD $27,776,448.00
- OPT $261,859.00
- Revenue This Year
- HKD N/A
- OPT N/A
- Revenue Next Year
- HKD N/A
- OPT $46,864.64
- P/E Ratio
- HKD $8.38
- OPT N/A
- Revenue Growth
- HKD N/A
- OPT N/A
- 52 Week Low
- HKD $2.61
- OPT $1.79
- 52 Week High
- HKD $6.18
- OPT $5.45
- Technical
- Relative Strength Index (RSI)
- HKD 34.68
- OPT 27.29
- Support Level
- HKD $3.00
- OPT $4.02
- Resistance Level
- HKD $3.04
- OPT $4.18
- Average True Range (ATR)
- HKD 0.19
- OPT 0.22
- MACD
- HKD -0.05
- OPT -0.13
- Stochastic Oscillator
- HKD 2.75
- OPT 6.85
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.